KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 121 days ( -5.92 % )
Last Price $16.10 0 %
High/ Low $16.10 - $16.10 0%
Chg 7 Days N/A $16.10 $16.10
Chg 30 Days N/A $16.10 $16.10
Chg 12 mos 72.93 % $9.31 $16.10
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 11.61 % Width: 91.33 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $11.93 - $22.83 -25.89 % - 41.79 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 23, 2022 - 122 days
Long MA avg 12 mos Buy Feb 24, 2022 - 121 days
Short/Long MA avg 12 mos Buy Mar 07, 2022 - 114 days
Pivot Short Sell Aug 16, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Ophthotech Corporation

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement fac... OPHT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT